Published in Semin Psychiatry on November 01, 1971
Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. JAMA (2003) 1.67
Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry (2008) 1.42
Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx (2005) 1.10
Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev (2012) 1.09
Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder. Front Neurosci (2012) 0.88
Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA. Br J Pharmacol (2001) 0.82
Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. Mol Psychiatry (2013) 0.81
Targeting modulation of noradrenalin release in the brain for amelioration of REMS loss-associated effects. J Transl Int Med (2015) 0.78
Effect of dietary fat type on anxiety-like and depression-like behavior in mice. Springerplus (2013) 0.78
A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans. J Psychiatry Neurosci (2003) 0.76
Bipolar disorder. Dialogues Clin Neurosci (1999) 0.75
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry (1993) 9.09
Reimmunization Against Diphtheria of Previously Immunized Children. Am J Public Health Nations Health (1942) 7.70
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry (1995) 7.19
Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry (1984) 4.72
Diphtheria Immunization with Fluid Toxoid and Alum-Precipitated Toxoid. Am J Public Health Nations Health (1942) 3.95
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav (1980) 3.69
Light suppresses melatonin secretion in humans. Science (1980) 3.45
A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry (1982) 2.75
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1) N Engl J Med (1988) 2.58
The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. Am J Psychiatry (1988) 2.58
Comparative Speed of Response of Previously Immunized and Non-Immunized Children to Fluid and Alum-Precipitated Diphtheria Toxoid. Am J Public Health Nations Health (1943) 2.49
Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res (1979) 2.45
The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry (1990) 2.41
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci (1983) 2.31
Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry (2000) 1.98
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N Engl J Med (1988) 1.95
Animal research versus humane use: the struggle to sustain our research advances. Interview by Edmund Kelly and Anthony Mazzaschi. FASEB J (1989) 1.94
Manic-depressive patients may be supersensitive to light. Lancet (1981) 1.91
Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry (1996) 1.84
Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry (1993) 1.80
Brain endolases as specific markers of neuronal and glial cells. Science (1978) 1.75
Diphtheria Studies: I-The Significance of the Schick Test in the Adult. Am J Public Health Nations Health (1934) 1.75
Diphtheria Immunization With Fluid Toxoid and Alum Precipitated Toxoid -Preliminary Report. Am J Public Health Nations Health (1939) 1.73
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology (1997) 1.63
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry (1982) 1.58
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci (1996) 1.50
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci U S A (2000) 1.37
Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry (1979) 1.33
GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex (1996) 1.31
Human aggression and suicide. Suicide Life Threat Behav (1986) 1.31
Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry (1982) 1.30
Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry (1993) 1.30
The stages of mania. A longitudinal analysis of the manic episode. Arch Gen Psychiatry (1973) 1.29
Leukocytosis during lithium treatment. Am J Psychiatry (1971) 1.27
A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry (1983) 1.26
Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry (1987) 1.26
Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci (1989) 1.25
Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry (1965) 1.24
Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry (1973) 1.21
Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system. Life Sci (1978) 1.20
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry (1982) 1.19
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Pertussis agglutinins in adults. Public Health Rep (1969) 1.16
Phase advance of the circadian sleep-wake cycle as an antidepressant. Science (1979) 1.16
Functional properties of neuronal and glial isoenzymes of brain enolase. J Neurochem (1978) 1.15
Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry (1969) 1.13
Antibody response to booster dose of diphtheria and tetanus toxoids: Reactions in institutionalized adults and non-institutionalized children and young adults. Public Health Rep (1963) 1.13
Stimulation by lithium of monoamine uptake in human platelets. Life Sci (1969) 1.11
PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry (1996) 1.11
Quantitative studies of norepinephrine uptake by synaptosomes. Biochem Pharmacol (1968) 1.11
A rapid and sensitive radioreceptor assay for benzodiazepine in plasma. Arch Gen Psychiatry (1979) 1.11
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol Dis (2003) 1.10
Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Res (1978) 1.10
Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet (1968) 1.09
The bipolar spectrum and the antidepressant view of the world. J Psychiatr Pract (2001) 1.07
The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep (1991) 1.07
Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochem (1979) 1.07
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Biol Psychiatry (1970) 1.07
Prediction of antidepressant responses to lithium. Am J Psychiatry (1978) 1.07
Effects of vasopressin on human memory functions. Science (1981) 1.07
Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature (1977) 1.07
Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. Arch Gen Psychiatry (1975) 1.06
Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry (1992) 1.05
The inheritance of affective disorders: a review of data and of hypotheses. Behav Genet (1976) 1.03
Blood platelets contain a neuron-specific enolase subunit. J Neurochem (1980) 1.03
Developmental profile of neuron-specific (NSE) and non-neuronal (NNE) enolase. Brain Res (1980) 1.03
Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry (1979) 1.03
Seasonal affective disorder: prevalence varies with latitude and climate. Clin Neuropharmacol (1986) 1.03
Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol Psychiatry (2003) 1.03
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) (1980) 1.02
Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch Gen Psychiatry (1983) 1.02
Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry (1987) 1.01
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry (1972) 1.00
Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry (1979) 1.00
Heritable factors in the severity of affective illness. Biol Psychiatry (1976) 1.00
Age-related changes in sleep in depressed and normal subjects. Psychiatry Res (1981) 0.99
Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry (1998) 0.99
Active metabolites of imipramine and desipramine in man. Clin Pharmacol Ther (1982) 0.99
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia (1974) 0.98
Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry (1996) 0.98